KRAS and ovarian carcinoma: This phenomenon was also observed in our previous studies wherein oncolytic VV with deletions of both VGF and O1 genes achieved tumor-selective replication in mouse models with xenograft tumors derived from ovarian carcinoma with wild-type KRAS [38,48].